Abstract 364P
Background
To develop artificial intelligence auto-segmentation model that generates consistent, high-quality lymph nodes contouring in head and neck cancer patients who received radiotherapy.
Methods
There were 60 computed tomography (CT) scans were retrospectively selected into training and another 60 CT scans were collected into cross-validation. All target delineations covered head and neck lymph node level I through V and based on the Radiation Therapy Oncology Group (RTOG) guideline. All targets were approved by radiation oncologists specializing in head and neck cancer. The volume of interest and all approved contours were used to train a 3D U-Net model. Different lymph node levels were trained independently. The trained model was used on cross-validation group. Auto-segmentations were revised by 2 radiation oncologists.
Results
The Dice Similarity Coefficients were 0.79 and 0.88 in trained group and cross-validation group. The volume changes ranged from -22.2 to 89.0 cm3. The center shift for x-direction, y-direction, and z-direction were -0.57 to 0.16 cm, -0.14 to 0.88 cm, and -0.19 to 0.38 cm, respectively.
Conclusions
We developed an artificial intelligence auto-segmentation model to autodelineate head and neck lymph nodes. Most results of auto-segmentations were acceptable after radiation oncologist review. This enables more efficient and consistent targeting of neck lymph nodes in radiation treatment planning.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The author.
Funding
Has not received any funding.
Disclosure
The author has declared no conflicts of interest.
Resources from the same session
143P - Ablation combined with tislelizumab in treating hepatocellular carcinoma: A phase II trial
Presenter: Yangxun Pan
Session: Poster Display
Resources:
Abstract
144P - Integrated clinical and genomic models using machine-learning methods to predict the efficacy of paclitaxel-based chemotherapy in patients with advanced gastric cancer from K-MASTER project
Presenter: Jwa Hoon Kim
Session: Poster Display
Resources:
Abstract
145P - Tislelizumab (TIS) + chemotherapy (Chemo)/chemoradiotherapy (CRT) as neoadjuvant treatment for resectable esophageal squamous cell carcinoma (R-ESCC)
Presenter: Longqi Chen
Session: Poster Display
Resources:
Abstract
146P - Phase (ph) Ib results of bemarituzumab (BEMA) added to capecitabine/oxaliplatin (CAPOX) or S-1/oxaliplatin (SOX) with or without nivolumab (NIVO) for previously untreated advanced gastric/gastroesophageal junction cancer (G/GEJC): FORTITUDE-103 study
Presenter: Keun-Wook Lee
Session: Poster Display
Resources:
Abstract
147P - Four-year overall survival (OS) update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma (uHCC)
Presenter: Stephen Chan
Session: Poster Display
Resources:
Abstract
148P - Safety and efficacy of atezolizumab (Atezo) + bevacizumab (Bev) in Japanese patients (pts) with unresectable hepatocellular carcinoma (uHCC): Preliminary analysis of a prospective, multicenter, observational study (ELIXIR)
Presenter: Teiji Kuzuya
Session: Poster Display
Resources:
Abstract
149P - A prospective observational study of MSI screening in unresectable chemotherapy-naïve advanced gastric cancer/gastroesophageal junction cancer: WJOG13320GPS
Presenter: Yukiya Narita
Session: Poster Display
Resources:
Abstract
150P - Anlotinib plus chemotherapy as first-line therapy for gastrointestinal tumor patients with unresectable liver metastasis: Updated results from a multi-cohort, multi-center phase II trial ALTER-G-001-cohort C
Presenter: Junwei Wu
Session: Poster Display
Resources:
Abstract
151P - Relationship between depth of response and early tumor shrinkage with overall survival in advanced pancreatic cancer
Presenter: EMIKA KUROKI
Session: Poster Display
Resources:
Abstract
152P - Interim analysis of the NAPOLEON-2 study: Safety evaluation of nanoliposomal irinotecan with fluorouracil and folinic acid for unresectable pancreatic cancer patients with prior biliary drainage
Presenter: Futa Koga
Session: Poster Display
Resources:
Abstract